Thiogenesis Therapeutics, Corp. (TTI)
Thiogenesis Therapeutics, Corp. is a diversified issuer with ~1% warrant dilution, 2 recent financings, and recent insider activity.
Price chart
- Ticker
- TTI
- Exchange
- TSXV
- Primary commodity
- diversified
- Sector
- mining
- Shares outstanding
- 51,835,956 As of 2026-06-22
Warrant overhang
1 active warrant series covering 524,559 shares (~1% potential dilution); nearest expiry 2029-06-01.
View warrant overhang tool →Dilution-true chart
Price history with the company's active warrant supply walls (amber) and free-trading unlock dates (violet) overlaid. Levels and dates are Pacific Time.
Recent financings
Private placements directory →Latest insider transaction
50,000 shares ($536,000) on 2026-07-01.
View insider activity →Recent news
Latest coverage: 30 days ago
- Thiogenesis Appoints Dr. Gilad Aharon to Its Board of Directorsquotemedia_newsfile · 2026-06-17
- TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stockquotemedia_pr_newswire · 2026-06-02
- TETRA TECHNOLOGIES, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCKquotemedia_pr_newswire · 2026-06-02
Profile assembled from Strikepoint News signal data — drill results, warrant filings, financings, insider transactions, and news. Drill rock value per tonne is the gross in-situ value at today's spot prices, recomputed live. This page is for informational purposes only and is not investment advice; verify against the original filings before drawing conclusions.